Momelotinib, also known as Cyt387, is an ATP-competitive inhibitor of Janus kinases 1 and 2 (JAK1/JAK2). It is a benzamide derivative used as an active pharmaceutical ingredient in the production of treatments for myelofibrosis.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1056634-68-4
Momelotinib dihydrochloride
janus kinase inhibitor
Momelotinib dihydrochloride monohydrate
active pharmaceutical ingredient
Acrivastine isomer Z
active pharmaceutical ingredient
(-)(3S,4R)-4-(4-FLUOROPHENYL)-3-(3,4-METHYLENEDIOXY-PHENOXYMETHYL)-N-BENZYLPIPERIDINE HYDROCHLORIDE
Active pharmaceutical ingredient impurity
Nateglinide
active pharmaceutical ingredient
Ent-Nateglinide
active pharmaceutical ingredient
4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzoic acid
Momelotinib metabolite M19
N-(cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide
ZVHNDZWQTBEVRY-UHFFFAOYSA-N
C1COCCN1C2=CC=C(C=C2)NC3=NC=CC(=N3)C4=CC=C(C=C4)C(=O)NCC#N